Session I:
September 4, 2024
1:00 – 3:30 PM ET
Examining Policies that Impact the Prostate Cancer Racial Disparity
This session will examine key policies in the areas of early detection screening, access to treatments, and areas of financial toxicity that have a direct impact on the prostate cancer racial disparity. Existing Policies will be examined from the perspectives of how they impact on the disparity, and how to make them more responsive to eliminating the disparity.
Session I Agenda
Watch Video Moderator: J. Jacques Carter, MD, MPH, Assistant Professor, Harvard Medical School
Watch Video Welcome: Thomas A. Farrington, PHEN President and Founder
Watch Video Remarks: U.S. Congressman Gregory Meeks, 5th District of New York
Watch Video Celebrating 20 Years of Summit – Part I: Ms. Tomeeka Miller, PHEN Director of Communications
Watch Video Why Early Detection Screening Policies and Guidelines Are Priority: Keith Crawford, MD, PhD, PHEN Director of Clinical Trials and Patient Education
Watch Video Financial Barriers to Prostate Cancer Diagnosis: The Rising Impact of Out-of-Pocket Costs: Arnav Srivastava, MD, PhD, Urologic Oncology, The University of Michigan Presentation Slides: 2024.09.04 – PHEN Talk v01
Watch Video Overview of the Facilitating Innovative Nuclear Diagnostics (FIND) Act: Mr. Ira Goldman, VP of Government Affairs, Lantheus Presentation Slides: FIND_Act_PHEN_Sept2024
Watch Video Panel Discussion on Prostate Cancer Policy Initiatives and Needs – Federal and State: Moderator: Mr. Anthony “Tony” Hill, PHEN Policy Coordinator
-
- Ms. Shonta Chambers, Executive Vice President of Health Equity Initiatives and Community Engagement, Patient Advocate Foundation (PAF)
- State Representative Goffrey A. “GA” Hardaway Sr., 93rd District of Tennessee
- State Representative Dontavius Jarrells, 1st District of Ohio
- Mr. James Williams, Director of Federal Relations, American Cancer Society
Closing Remarks: Dr. J. Jacques Carter
SPONSORS
PHEN thanks its sponsors for their support of the 2024 Summit.
